Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE5.1300
- TODAY'S CHANGE (%)0.7600 (17.3913%)
- Bid / Lots4.9300/ 7
- Ask / Lots5.1200/ 1
- Open / Previous Close4.4400 / 4.3700
- Day Range
- 52 Week Range
- Volume1,504,571
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 4380 | 4.5 |
| 09:34 ET | 1410 | 4.48 |
| 09:36 ET | 1345 | 4.46 |
| 09:38 ET | 300 | 4.475 |
| 09:39 ET | 200 | 4.475 |
| 09:41 ET | 1500 | 4.435 |
| 09:43 ET | 394 | 4.41 |
| 09:45 ET | 1000 | 4.475 |
| 09:48 ET | 1151 | 4.52 |
| 09:50 ET | 200 | 4.545 |
| 09:52 ET | 350 | 4.5201 |
| 09:54 ET | 392 | 4.5216 |
| 09:56 ET | 619 | 4.558 |
| 09:57 ET | 1717 | 4.55 |
| 09:59 ET | 1210 | 4.5075 |
| 10:01 ET | 508 | 4.505 |
| 10:03 ET | 200 | 4.48 |
| 10:06 ET | 1025 | 4.48 |
| 10:08 ET | 1268 | 4.51 |
| 10:12 ET | 1086 | 4.53 |
| 10:14 ET | 300 | 4.54 |
| 10:15 ET | 100 | 4.55 |
| 10:17 ET | 2272 | 4.52 |
| 10:19 ET | 16155 | 4.51 |
| 10:21 ET | 1791 | 4.52 |
| 10:24 ET | 1700 | 4.5121 |
| 10:26 ET | 6952 | 4.48 |
| 10:28 ET | 394 | 4.48 |
| 10:30 ET | 890 | 4.48 |
| 10:32 ET | 3204 | 4.4501 |
| 10:33 ET | 6045 | 4.48 |
| 10:35 ET | 2596 | 4.51 |
| 10:37 ET | 500 | 4.53 |
| 10:39 ET | 1358 | 4.53 |
| 10:42 ET | 2723 | 4.55 |
| 10:44 ET | 7496 | 4.635 |
| 10:46 ET | 2938 | 4.69 |
| 10:48 ET | 4006 | 4.68 |
| 10:50 ET | 24294 | 4.76 |
| 10:51 ET | 5876 | 4.81 |
| 10:53 ET | 88384 | 4.8682 |
| 10:55 ET | 5259 | 4.79 |
| 10:57 ET | 6428 | 4.8 |
| 11:00 ET | 1709 | 4.8161 |
| 11:02 ET | 18773 | 4.9 |
| 11:04 ET | 22593 | 4.89 |
| 11:06 ET | 3437 | 4.93 |
| 11:08 ET | 4999 | 4.9487 |
| 11:09 ET | 3749 | 4.945 |
| 11:11 ET | 31075 | 4.95 |
| 11:13 ET | 34975 | 5.0082 |
| 11:15 ET | 4729 | 4.99 |
| 11:18 ET | 83352 | 4.99 |
| 11:20 ET | 888 | 4.98 |
| 11:22 ET | 4976 | 4.9518 |
| 11:24 ET | 7302 | 4.87 |
| 11:26 ET | 5034 | 4.8983 |
| 11:27 ET | 16245 | 4.84 |
| 11:29 ET | 1260 | 4.83 |
| 11:31 ET | 3044 | 4.81 |
| 11:33 ET | 1179 | 4.81 |
| 11:36 ET | 2414 | 4.835 |
| 11:38 ET | 100 | 4.85 |
| 11:40 ET | 100 | 4.835 |
| 11:42 ET | 1476 | 4.85 |
| 11:44 ET | 798 | 4.85 |
| 11:45 ET | 500 | 4.85 |
| 11:47 ET | 10248 | 4.85 |
| 11:49 ET | 3327 | 4.89 |
| 11:51 ET | 29894 | 4.905 |
| 11:54 ET | 29415 | 4.925 |
| 11:56 ET | 650 | 4.93 |
| 11:58 ET | 27166 | 4.97 |
| 12:00 ET | 1719 | 4.98 |
| 12:02 ET | 2400 | 4.955 |
| 12:03 ET | 1445 | 4.955 |
| 12:05 ET | 3110 | 4.96 |
| 12:07 ET | 300 | 4.955 |
| 12:09 ET | 2448 | 4.97 |
| 12:12 ET | 2200 | 4.96 |
| 12:14 ET | 2238 | 4.955 |
| 12:16 ET | 6254 | 4.98 |
| 12:18 ET | 3150 | 4.945 |
| 12:20 ET | 3104 | 4.92 |
| 12:21 ET | 4297 | 4.95 |
| 12:23 ET | 700 | 4.94 |
| 12:25 ET | 3458 | 4.97 |
| 12:27 ET | 6293 | 4.94 |
| 12:30 ET | 1000 | 4.93 |
| 12:32 ET | 700 | 4.91 |
| 12:36 ET | 18193 | 4.935 |
| 12:38 ET | 3266 | 4.939 |
| 12:39 ET | 2580 | 4.9818 |
| 12:41 ET | 16585 | 5 |
| 12:43 ET | 13184 | 5 |
| 12:45 ET | 7822 | 4.98 |
| 12:48 ET | 3003 | 4.95 |
| 12:50 ET | 1499 | 4.9401 |
| 12:52 ET | 1240 | 4.97 |
| 12:54 ET | 600 | 4.98 |
| 12:56 ET | 4852 | 4.98 |
| 12:57 ET | 4569 | 4.98 |
| 12:59 ET | 100 | 4.99 |
| 01:01 ET | 4214 | 4.98 |
| 01:03 ET | 900 | 4.98 |
| 01:06 ET | 300 | 4.975 |
| 01:08 ET | 1100 | 4.98 |
| 01:10 ET | 3625 | 4.995 |
| 01:12 ET | 6155 | 5 |
| 01:14 ET | 5862 | 5 |
| 01:15 ET | 600 | 4.99 |
| 01:17 ET | 3374 | 4.99 |
| 01:19 ET | 500 | 4.995 |
| 01:21 ET | 3576 | 5 |
| 01:24 ET | 11666 | 4.96 |
| 01:26 ET | 100 | 4.97 |
| 01:28 ET | 709 | 4.965 |
| 01:30 ET | 7168 | 4.95 |
| 01:32 ET | 1000 | 4.95 |
| 01:33 ET | 1244 | 4.95 |
| 01:37 ET | 2920 | 4.95 |
| 01:42 ET | 713 | 4.955 |
| 01:44 ET | 6441 | 4.9 |
| 01:46 ET | 922 | 4.8924 |
| 01:48 ET | 2938 | 4.9012 |
| 01:50 ET | 100 | 4.9047 |
| 01:51 ET | 2200 | 4.895 |
| 01:53 ET | 800 | 4.89 |
| 01:55 ET | 400 | 4.89 |
| 01:57 ET | 266 | 4.9 |
| 02:00 ET | 100 | 4.9 |
| 02:02 ET | 1467 | 4.92 |
| 02:04 ET | 200 | 4.93 |
| 02:06 ET | 2449 | 4.92 |
| 02:08 ET | 327 | 4.93 |
| 02:09 ET | 400 | 4.93 |
| 02:11 ET | 242 | 4.93 |
| 02:13 ET | 7275 | 4.89 |
| 02:15 ET | 5497 | 4.91 |
| 02:22 ET | 1329 | 4.895 |
| 02:24 ET | 2809 | 4.9 |
| 02:27 ET | 1800 | 4.892 |
| 02:29 ET | 1009 | 4.88 |
| 02:31 ET | 2700 | 4.875 |
| 02:33 ET | 3747 | 4.86 |
| 02:38 ET | 2905 | 4.845 |
| 02:40 ET | 5729 | 4.81 |
| 02:42 ET | 2700 | 4.835 |
| 02:44 ET | 750 | 4.8303 |
| 02:47 ET | 325 | 4.8313 |
| 02:49 ET | 2836 | 4.83 |
| 02:51 ET | 1984 | 4.86 |
| 02:54 ET | 2539 | 4.86 |
| 02:56 ET | 1809 | 4.87 |
| 03:00 ET | 5749 | 4.92 |
| 03:02 ET | 5974 | 4.95 |
| 03:03 ET | 2784 | 4.96 |
| 03:05 ET | 3910 | 4.95 |
| 03:07 ET | 500 | 4.955 |
| 03:09 ET | 1735 | 4.96 |
| 03:12 ET | 3939 | 4.96 |
| 03:14 ET | 6081 | 4.9399 |
| 03:18 ET | 703 | 4.93 |
| 03:20 ET | 7992 | 4.94 |
| 03:21 ET | 15410 | 4.95 |
| 03:23 ET | 3517 | 4.95 |
| 03:25 ET | 3582 | 4.95 |
| 03:27 ET | 560 | 4.955 |
| 03:30 ET | 18512 | 4.96 |
| 03:32 ET | 98411 | 4.99 |
| 03:34 ET | 7047 | 4.99 |
| 03:36 ET | 4900 | 5.01 |
| 03:38 ET | 5969 | 5.01 |
| 03:39 ET | 1609 | 5 |
| 03:41 ET | 436 | 4.995 |
| 03:43 ET | 2494 | 5 |
| 03:45 ET | 4069 | 5.025 |
| 03:48 ET | 815 | 5.025 |
| 03:50 ET | 16694 | 5.12 |
| 03:52 ET | 54718 | 5.125 |
| 03:54 ET | 6082 | 5.18 |
| 03:56 ET | 41422 | 5.146 |
| 03:57 ET | 20057 | 5.15 |
| 03:59 ET | 100498 | 5.13 |
May 20, 2024
May 17, 2024
May 16, 2024
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences, from 4:05PM ET on Thursday May 16, 2024 by Dow Jones
4:05PM ET on Thursday May 16, 2024 by Dow JonesPress Release: Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer, from 8:00AM ET on Thursday May 16, 2024 by Dow Jones
8:00AM ET on Thursday May 16, 2024 by Dow JonesVentyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer, from 8:00AM ET on Thursday May 16, 2024 by Dow Jones
8:00AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 308.1M | -1.6x | --- |
Atea Pharmaceuticals Inc | 308.3M | -1.8x | --- |
Solid Biosciences Inc | 299.0M | -1.9x | --- |
Q32 Bio Inc | 310.5M | -1.0x | --- |
Replimune Group Inc | 320.6M | -1.6x | --- |
ESSA Pharma Inc | 283.5M | -10.0x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Operating Officer
- Matthew Moore
- Chief Scientific Officer
- John Nuss
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $308.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
